Kronos Bio

Kronos Bio

    Company info:

  • 101-250
  • 2017
  • San Mateo, CA
  • 100-500M

Claim company profile

About company:

Kronos Bio is developing therapeutics that target dysregulated transcription that underpins most human diseases. Individual transcription factors, which dictate expression of a subset of genes, have been attractive drug targets but have achieved little success. Instead, Kronos is analyzing the total transcriptional regulatory network (TRNs) of diseased cells to identify critical nodes responsible for a transcription factor's activity. This approach circumvents the need to focus on a single transcription factor and offers many avenues to target. Kronos has identified three investigational compounds that are being investigated in cancer patients. This includes two oral SYK inhibitors. SYK is a critical node in the dysregulated TRN of acute myeloid leukemia.


Kronos Bio
Associate Director/Director, Drug Safety Operation...
San Mateo, CA|26 days ago
Kronos Bio
Medical Director, Clinical Development
San Mateo, CA|39 days ago
Kronos Bio
Manager, Chemical Development
San Mateo, CA|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy